Drug Evaluation Research

ISSN 1674-6376Tianjin Press of Chinese Herbal MedicinesChina
ScopusMEDLINEEmbaseSCImagoMatched via identifier

Journal overview

Titles
Drug Evaluation Research
Drug. Eval. Res. (abbreviated)
ISSN
1674-6376
eISSN
Not available
NLM ID
Not available
Publisher
Tianjin Press of Chinese Herbal Medicines
Country
Language
CHI

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2019–2026
Indexing services (MEDLINE, Embase)
MEDLINEUnknownEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
Not available
Full-text availability (PMC — not an indexing service)
Not available

Metrics

JIF
Not available
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.138
Best Quartile
Q4
H-index
10
Subject categories
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous) — Q4
More metrics
Coverage
2019–2026
Country
China
Region
Asiatic Region
Publisher
Tianjin Press of Chinese Herbal Medicines
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
346
Total documents (3 years)
850
Total references
13178
Total citations (3 years)
349
Citable documents (3 years)
850
Citations per document (2 years)
0.5
References per document
38.09
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
1674-6376
SCImago Source ID
21101092871
SCImago Rank (across all SCImago source types)
26365

Publication activity

Publication activity
2025
346 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Not available
Scopus:2019-2026